JP
Insider
John Paulson
DirectorJohn Paulson (Director) filed 4 Form 4 reports in the past 24 months (4 purchases, 0 sales), most often in Bausch Health Companies Inc. (BHC). Across 4 priced purchase filings, the average 21-session return was +17.6% from execution and +8.1% from disclosure (delay-adjusted; derived). The largest single filing was $312.5M of BHC (34,721,118 sh × $9.00, as filed), executed Aug 14 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+17.6%
avg across 4 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+8.1%
same 4 filings, from disclosure
Filings, ttm
4
4 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$369.6M
shares × price, as filed
Last traded
Aug 14 2025
Filed Aug 14 2025
Median ADV $23.4M across their filed names
Open performance→Volume by month
Buys $369.6M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 24 months
Most traded names
BHCRecent filings
BHCPURCHASE
Bausch Health Companies Inc.
View filing →
$312.5M34,721,118 sh × $9.00
Exec Aug 14 2025
Filed Aug 14 2025 · 9:35 PM ET BHCPURCHASE Bausch Health Companies Inc. View filing → $21.3M
3,243,049 sh across 3 lots
Exec Aug 11 2025
Filed Aug 13 2025 · 6:51 PM ET BHCPURCHASE Bausch Health Companies Inc. View filing → $21.2M
3,564,059 sh × $5.94
Exec Jun 13 2025
Filed Jun 17 2025 · 5:30 PM ET BHCPURCHASE Bausch Health Companies Inc. View filing → $14.7M
2,788,608 sh across 3 lots
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET